Parkinson's ... cell replacement therapies by ensuring a more homogenous and effective graft[4]. Finally, the preclinical development of a human embryonic stem cell-derived product for PD ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease ... Chines about a new treatment for ...

Bayer subsidiary BlueRock Therapeutics has dosed the first Parkinson's ... disease progresses. In the BlueRock trial, an unnamed patient has now been administered the first dose of pluripotent ...

Many degenerative diseases, like Parkinson’s disease, multiple sclerosis, or heart failure, have always been concerning when it comes to ...

such as developing treatments for Parkinson's disease, were explored in qualitative studies. Participants generally supported the use of embryonic stem cells for therapeutic purposes, provided ...

Results from rhesus macaques provide solid ground for a first-in-human investigation of heart repair with stem cell-derived ...

A patch made from lab-grown muscle cells boosted heart function in monkeys with cardiovascular disease and is now being ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

Jan. 28, 2025 — A team of stem cell scientists have successfully used embryonic stem cell engineering to create a bi-paternal mouse -- a mouse with two male parents -- that lived until adulthood.

A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...

A radically upgraded Parkinson’s treatment which zaps the brain ... people in the UK live with Parkinson’s disease, caused by a loss of nerve cells in the brain. Older men and those with ...